ReviewCancer immunology, immunotherapy : CII2024

Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.

Xingchen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.